Consensus statement for treatment protocols in pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Pleura and Peritoneum

Murphy Jamie¹  Yong Wei Peng²  Delgadillo Xavier³  Eveno Clarisse⁴  Ceelen Wim⁵  Kefleyesus Amaniel⁶  Bakrin Naoual⁶  Alyami Mohammad⁷  Guiral Delia Cortes⁷  Dellinger Thanh⁸  Tempfer Clemens⁹  Rovers Koen P.^1,10  Mortensen Michael Bau^1,11  Reymond Marc^1,12  Sgarbura Olivia^1,13  Somashekhar S.P.^1,14  Van der Speeten Kurt^1,15  Hübner Martin^1,16  So Jimmy^1,17  Villeneuve Laurent^1,18  Khomiakov Vladimir^1,19  Di Giorgio Andrea^2,20  Robella Manuela^2,21  Pocard Marc^2,22 

[1] Academic Surgical Unit, Imperial College Healthcare NHS Trust, London, UK;Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore;Centre Médico Chirurgical Volta, Unité Spécialisée de Chirurgie, La Chaux-de-Fonds, Switzerland;Department of Digestive and Oncological Surgery, University of Lille, Claude Huriez University Hospital, Lille, France;Department of GI Surgery, Ghent University Hospital, Ghent, Belgium;Department of General Surgery & Surgical Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France;Department of General Surgery and Surgical Oncology, Oncology Center, King Khalid Hospital, Najran, Saudi Arabia;Department of Gynecologic Oncology, City of Hope National Medical Center, Duarte, CA, USA;Department of Obstetrics and Gynecology and Therapy Center for Peritoneal Carcinomatosis, Marien Hospital Herne, Ruhr-Universität Bochum, Herne, Germany;Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands;Department of Surgery, Odense Pancreas Center (OPAC) & Odense PIPAC Center (OPC), Odense University Hospital, Odense, Denmark;Department of Surgery, University of Tübingen, Tübingen, Germany;Department of Surgical Oncology, Cancer Institute of Montpellier, University of Montpellier, Montpellier, France;Department of Surgical Oncology, Manipal Comprehensive Cancer Center, Manipal Hospital, Bangalore, India;Department of Surgical Oncology, Ziekenhuis Oost-Limburg, Genk, Belgium;Department of Visceral Surgery, Lausanne University Hospital CHUV, University of Lausanne (UNIL), Lausanne, Switzerland;Division of Surgical Oncology, National University Cancer Institute, Singapore, Singapore;Lyon University 1, EA 3738 CICLY, Lyon, France;P.A. Hertsen Moscow Research Oncological Institute – Branch of the National Medical Research Center of Radiology, Moscow, Russia;Peritoneal and Retroperitoneal Surgical Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy;Unit of Surgical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Turin, Italy;Université de Paris, INSERM, U1275 CAP Paris-Tech, Paris, France;

关键词: cisplatin;    doxorubicin;    oxaliplatin;    peritoneal metastasis;    pipac;    standardisation;    treatment protocol;   

DOI  :  10.1515/pp-2022-0102

来源: DOAJ

【 摘 要 】

Safe implementation and thorough evaluation of new treatments require prospective data monitoring and standardization of treatments. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a promising alternative for the treatment of patients with peritoneal disease with an increasing number of suggested drug regimens. The aim was to reach expert consensus on current PIPAC treatment protocols and to define the most important research topics.

【 授权许可】

Unknown